Estimaciones de analistas de Wall Street para MindWalk Holdings Corp. (HYFT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-21 | $-0.04 | ||
| 2026-09-14 | $-0.09 | $-0.05 | -64.7% |
| 2026-07-22 | $-0.06 | $-0.05 | -12.8% |
| 2026-03-12 | $-0.06 | $-0.04 | -50.0% |
| 2025-12-15 | $-0.05 | $-0.01 | -400.0% |
| 2025-09-15 | $-0.07 | $-0.04 | -75.0% |
| 2025-07-29 | $-0.04 | $-0.02 | -100.0% |
| 2025-03-28 | $-0.06 | $-0.06 | +0.0% |
Ratios de valoración
| Precio / Valor contable | 10.70 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $2.6M | $5.4M | $10.9M | $14.7M | $17.9M | $19.4M | $20.7M | $24.5M | $24.5M | $15.3M |
| Coste de Ventas | $1.2M | $3.0M | $5.6M | $15.3M | $6.4M | $8.4M | $9.1M | $12.5M | $11.0M | $6.3M |
| Beneficio Bruto | $1.4M | $2.5M | $5.3M | -$576292 | $11.5M | $11.0M | $11.6M | $12.1M | $13.5M | $9.0M |
| I+D | $660408 | $509248 | $485845 | $467292 | $2.0M | $7.7M | $14.1M | $4.0M | $4.9M | $4.9M |
| Generales y Administrativos | $2.0M | $5.8M | $8.1M | $3.2M | $13.3M | $18.1M | $19.0M | $19.1M | $19.0M | $18.9M |
| Gastos Operativos | $2.8M | $7.4M | $11.5M | $3.7M | $15.7M | $27.7M | $37.2M | $25.8M | $25.7M | $23.7M |
| Beneficio Operativo | -$1.4M | -$4.9M | -$6.2M | -$4.3M | -$4.2M | -$16.7M | -$25.6M | -$13.8M | -$12.2M | -$14.7M |
| EBITDA | -$5.4M | -$4.3M | -$4.0M | -$1.2M | -$1.4M | -$12.0M | -$21.0M | -$22.9M | -$28.9M | -$13.1M |
| Gastos por Intereses | $16775 | $84222 | $858323 | $736272 | $602372 | $85000 | $30000 | $19000 | $9914 | 0 |
| Beneficio Antes de Impuestos | -$5.5M | -$5.1M | -$7.6M | -$5.5M | -$6.0M | -$15.8M | -$27.8M | -$28.7M | -$34.3M | -$15.3M |
| Impuestos | -$82378 | $109715 | $4788 | -$362004 | $1.3M | $861000 | -$1.2M | -$2.6M | -$4.0M | -$443097 |
| Beneficio Neto | -$5.4M | -$5.2M | -$7.6M | -$5.2M | -$7.3M | -$16.7M | -$26.6M | -$26.1M | -$30.2M | -$13.7M |
| BPA | $-1.36 | $-0.57 | $-0.61 | $-0.36 | $-0.45 | $-0.87 | $-1.07 | $-1.03 | $-0.90 | $-0.30 |
| BPA Diluido | $-1.36 | $-0.57 | $-0.61 | $-0.36 | $-0.45 | $-0.87 | $-1.07 | $-1.03 | $-0.90 | $-0.30 |
| Acciones en Circulación (Diluidas) | $4.0M | $9.1M | $12.5M | $13.6M | $16.5M | $19.7M | $24.9M | $25.6M | $33.4M | $46.4M |
Precio
| Precio | $1.13 |
| Capitalización | $53M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALXO · ATYR · BYSI · CAMP · CLNN · FBIO · GUTS
Explorar sector: Healthcare · Biotechnology
Más secciones de HYFT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones